Sort
261,768 grants matching “gene therapy”
Systems Biology Approaches to Viral Pathogenesis and Immunity
$976,964Michael G Katze · Oregon Health & Science University · U54 · FY2012 · AI
Preclinical and Early Clinical Development of a Novel Drug for On-Demand Voiding
$976,908Edward Burgard · Dignify Therapeutics, Llc · U44 · FY2025 · NS
The TGFÃÂÃÂÃÂÃÂÃÂÃÂÃÂò Signaling Pathway in Development and Cancer
$976,871Joan Massague · Sloan-Kettering Inst Can Research · R35 · FY2024 · CA
The Monarch Initiative: Linking Diseases to Model Organism Resources
$976,859Melissa A Haendel · Oregon Health & Science University · R24 · FY2016 · OD
A Precision Medicine for Alcohol-Associated Liver Disease
$976,742Wanqing Liu · Genetobe Inc. · UT2 · FY2023 · AA
The Role of Host Factors in HIV Immunopathogenesis
$976,696Anthony S. Fauci · National Institute Of Allergy And Infectious Diseases · Z01 · FY2008 · AI
The Colon Cancer Family Registry: Ontario
$976,693Steven Gallinger · Cancer Care Ontario · U24 · FY2010 · CA
Bay Area Cancer Target Discovery and Development
$976,551Michael T McManus · University Of California, San Francisco · U01 · FY2023 · CA
1/2 Prospective tReatment EffiCacy in IPF uSlng genOtype for Nac Selection (PRECISIONS) trial and Molecular Endophenotyping in Idiopathic Pulmonary Fibrosis and Interstitial Lung Diseases study
$976,537Fernando J Martinez · Weill Medical Coll Of Cornell Univ · UG3 · FY2019 · HL
BMX-001 as a Therapeutic Agent for Treatment of High-Grade Gliomas
$976,447James D Crapo · Biomimetix Jv, Llc · R44 · FY2015 · CA
Development of Ciclopirox Prodrug as a Novel Systemic Treatment for High-Risk Non-Muscle Invasive Bladder Cancer
$976,393William Mc Culloch · Ciclomed, Llc · R44 · FY2021 · CA
IND Enabling Studies and Manufacturing Scale Up of Human Placental Extract to Prevent Surgical Necrotizing Enterocolitis
$976,322Michael Bentley Berger · Plakous Therapeutics, Inc. · R44 · FY2025 · HD
Integrating targeted therapy and immunotherapy to break through cancer
$976,251Jean Zhao · Dana-Farber Cancer Inst · R35 · FY2024 · CA
CAREER: Maternal age effects in an ecologically-important aquatic invertebrate: Genetic and epigenetic controls and fitness outcomes in variable environments
$976,177Kristin Gribble · Marine Biological Laboratory · · FY2020 · BIO
Novel Dopamine D3/D2 Receptor Ligands
$976,135Amy Hauck Newman · National Institute On Drug Abuse · ZIA · FY2025 · DA
A Novel Glycosaminoglycan-Based Therapeutic for Chronic Rhinosinusitis
$976,018Justin Rodney Savage · Glycomira, Llc · R44 · FY2022 · AI
Gene Therapy and Hematopoietic Stem Cell Research to Treat Inherited Primary Immune Deficiencies
$976,015Harry L Malech · National Institute Of Allergy And Infectious Diseases · ZIA · FY2023 · AI
Development of a Technology Platform for Engineering Single-Administration HIV Therapeutics
$975,928Leor S Weinberger · J. David Gladstone Institutes · R56 · FY2019 · AI
A Solid-Phase, Long-Acting CCR5 Monoclonal Antibody for HIV Transmission
$975,920Jonah B. Sacha · Oregon Health & Science University · R01 · FY2023 · AI
HER2-targeted exosomal delivery of therapeutic mRNA for enzyme pro-drug therapy
$975,880Ac Matin · Stanford University · UH3 · FY2016 · TR
HER2-targeted exosomal delivery of therapeutic mRNA for enzyme pro-drug therapy
$975,880Ac Matin · Stanford University · UH3 · FY2017 · TR
Impact of IL-15 immunotherapy on tissue-specific CD8 T cells to reduce the CNS HIV reservoir seeding and persistence
$975,768Lydie Trautmann · Henry M. Jackson Fdn For The Adv Mil/Med · R01 · FY2024 · MH
Cerebral Structural And Metabolic Correlates Of Aggressive Or Addictive Behavior
$975,764Daniel W Hommer · National Institute On Alcohol Abuse And Alcoholism · ZIA · FY2011 · AA
Rehabilitation Medicine Scientist Training (RMST) Program
$975,602John Whyte · Moss Rehabilitation Hospital · K12 · FY2007 · HD
GUANYLYL CYCLASE C AS A BI0MARKER FOR COLORECTAL CANCER
$975,547Thomas Jefferson University · R01 · FY2003 · CA